HER2 expression was assessed in four oral cancer cell lines of different origin, including Ca9-22 (gingiva), HO-1-u-1 (mouth floor), HSC-2 (oral cavity), and SAS (tongue). This evidence concerns the gene ERBB2 and lip and oral cavity carcinoma.